Javascript must be enabled to continue!
Risk-score performance for detecting transthyretin cardiac amyloidosis in severe aortic stenosis: a prospective cohort study
View through CrossRef
Introduction
The coexistence of transthyretin cardiac amyloidosis (ATTR-CA) and severe aortic stenosis (AS) presents a diagnostic challenge. This study aimed to determine the prevalence of this dual pathology and to assess the effectiveness of diagnostic models in enhancing detection accuracy.
Methods
We conducted a prospective study of 104 consecutive patients with severe AS (aortic valve area <1 cm
2
). Comprehensive evaluation included clinical and laboratory assessments, electrocardiography, transthoracic echocardiography, planar whole-body bone scintigraphy, and chest single-photon emission computed tomography/computed tomography using technetium-99m-labelled 3,3-diphosphono-1,2-propanodicarboxylic acid tracer. Patients were grouped according to the presence of ATTR-CA, and the diagnostic utility of the RAISE score, its variations, and the T-AMYLO score was evaluated.
Results
Nineteen (18%) patients with AS also had ATTR-CA (ATTR-CA-AS). They were significantly older (82.6 ± 7.4 vs. 76 ± 6.9,
p
< 0.001), more often had arrhythmic and conduction disorders (atrial fibrillation, implanted pacemakers), and had a reduced left ventricular ejection fraction (44.6% vs. 54.7%,
p
= 0.03). Patients with ATTR-CA-AS more frequently presented with the low-gradient/low-flow phenotype of AS (73.7%,
p
= 0.009). Both NT-proBNP and troponin levels were significantly higher in patients with ATTR-CA-AS (4174.0 vs. 1,238 pg/mL;
p
< 0.001; and 59.6 vs. 23.3 ng/L,
p
< 0.001, respectively). After a 6-month follow-up, a similar number of deaths occurred in both groups, and no surgical aortic valve replacement was performed in the ATTR-CA-AS population. The eRAISE model demonstrated the highest diagnostic accuracy (AUC=0.948).
Conclusions
ATTR-CA is commonly observed in patients with severe AS. Implementing risk scores in routine practice could enhance the diagnostic accuracy of ATTR-CA in patients with AS, given their strong diagnostic performance and ease of assessment.
Title: Risk-score performance for detecting transthyretin cardiac amyloidosis in severe aortic stenosis: a prospective cohort study
Description:
Introduction
The coexistence of transthyretin cardiac amyloidosis (ATTR-CA) and severe aortic stenosis (AS) presents a diagnostic challenge.
This study aimed to determine the prevalence of this dual pathology and to assess the effectiveness of diagnostic models in enhancing detection accuracy.
Methods
We conducted a prospective study of 104 consecutive patients with severe AS (aortic valve area <1 cm
2
).
Comprehensive evaluation included clinical and laboratory assessments, electrocardiography, transthoracic echocardiography, planar whole-body bone scintigraphy, and chest single-photon emission computed tomography/computed tomography using technetium-99m-labelled 3,3-diphosphono-1,2-propanodicarboxylic acid tracer.
Patients were grouped according to the presence of ATTR-CA, and the diagnostic utility of the RAISE score, its variations, and the T-AMYLO score was evaluated.
Results
Nineteen (18%) patients with AS also had ATTR-CA (ATTR-CA-AS).
They were significantly older (82.
6 ± 7.
4 vs.
76 ± 6.
9,
p
< 0.
001), more often had arrhythmic and conduction disorders (atrial fibrillation, implanted pacemakers), and had a reduced left ventricular ejection fraction (44.
6% vs.
54.
7%,
p
= 0.
03).
Patients with ATTR-CA-AS more frequently presented with the low-gradient/low-flow phenotype of AS (73.
7%,
p
= 0.
009).
Both NT-proBNP and troponin levels were significantly higher in patients with ATTR-CA-AS (4174.
0 vs.
1,238 pg/mL;
p
< 0.
001; and 59.
6 vs.
23.
3 ng/L,
p
< 0.
001, respectively).
After a 6-month follow-up, a similar number of deaths occurred in both groups, and no surgical aortic valve replacement was performed in the ATTR-CA-AS population.
The eRAISE model demonstrated the highest diagnostic accuracy (AUC=0.
948).
Conclusions
ATTR-CA is commonly observed in patients with severe AS.
Implementing risk scores in routine practice could enhance the diagnostic accuracy of ATTR-CA in patients with AS, given their strong diagnostic performance and ease of assessment.
Related Results
Perspective Chapter: Lipoprotein (a), Cardiac Amyloidosis, and Aortic Stenosis - Underestimated Associations
Perspective Chapter: Lipoprotein (a), Cardiac Amyloidosis, and Aortic Stenosis - Underestimated Associations
This chapter aims to address two peculiar aspects of pathophysiology and clinical management of aortic valve stenosis, such as coexistence with cardiac amyloidosis and association ...
Anemia and outcome in cardiac amyloidosis
Anemia and outcome in cardiac amyloidosis
Abstract
Background
Anemia is a common comorbidity in patients with cardiac amyloidosis, yet its prognostic significance ...
Blood pressure, hypertension, and the risk of aortic aneurysm in the UK Biobank
Blood pressure, hypertension, and the risk of aortic aneurysm in the UK Biobank
Abstract
Background
Although an association between elevated blood pressure and risk of aortic aneurysm is established, f...
Critical Arterial Stenosis Revisited
Critical Arterial Stenosis Revisited
Abstract
Introduction
Stenosis of an organ/tissue primary artery can produce ischemia or only reduce blood flow reserve. Despit...
Acquired Supravalvular Aortic Stenosis: Review of a Rare Conundrum with Diverse Etiologies
Acquired Supravalvular Aortic Stenosis: Review of a Rare Conundrum with Diverse Etiologies
Background
Supravalvular aortic stenosis is a rare form of left ventricular outflow tract obstruction. Classically, supravalvular aortic stenosis occurs seconda...
Updates on Emerging Therapies in Cardiac Light Chain (AL) Amyloidosis
Updates on Emerging Therapies in Cardiac Light Chain (AL) Amyloidosis
Introduction:
Amyloidosis is a disorder where misfolded proteins get deposited in different tissues. The most common of them is immunoglobulin light chain (AL) depos...
Incidence, Outcomes and Predictors of Aortic Regurgitation After Transcatheter Aortic Valve Replacement in Al Azhar University Hospitals and National Heart Institute, Egypt
Incidence, Outcomes and Predictors of Aortic Regurgitation After Transcatheter Aortic Valve Replacement in Al Azhar University Hospitals and National Heart Institute, Egypt
Background: Aortic regurgitation (AR), which has ill-defined predictors and an unknown long-term influence on outcomes, is a significant transcatheter aortic valve replacement (TAV...
Cardiomyopathies with left ventricular hypertrophy phenotype: prevalence of cardiac amyloidosis and clinical characteristics of patients
Cardiomyopathies with left ventricular hypertrophy phenotype: prevalence of cardiac amyloidosis and clinical characteristics of patients
Cardiac amyloidosis was long considered a rare disease, primarily affecting the elderly. However, recent studies have demonstrated a higher prevalence, highlighting the need for fu...

